Efficacy and safety of DPP-4 inhibitor in the treatment of patients with COVID-19 combined with diabetes mellitus A protocol for systematic review and meta-analysis4900 Published on 2020-10-092022-10-30 Journal: Medicine [Category] COVID-19, MERS, SARS, [키워드] adverse outcomes Adverse reactions Analysis blood glucose CBM clinical evidence Clinical improvement clinical trial CNKI Cochrane Library conducted COVID-19 COVID-19 mortality COVID-19 patient Data analysis database diabete diabetes Diabetes Mellitus DPP-4 inhibitors effective Effectiveness Evidence fasting blood fasting insulin Glucose glycosylated hemoglobin include increase independent risk factor Infectious disease inhibitor interleukin-6 Meta-analysis metabolic disease morbidity mortality rate patients with COVID-19 peer-reviewed Primary outcome protocol Randomized controlled trials Registration review shown Symptom systematic review Treatment tumor necrosis factor-alpha VIP Web of Science with COVID-19 [DOI] 10.1097/MD.0000000000022592 PMC 바로가기 [Article Type] 4900
Acyclovir-induced immune thrombocytopenia: Case report and review of the literatureArticle Published on 2020-10-072024-09-04 Journal: Experimental and Therapeutic Medicine [Category] 대상포진, [키워드] acyclovir Adverse reactions drug induced herpes zoster thrombocytopenia [DOI] 10.3892/etm.2020.8971 PMC 바로가기 [Article Type] Article
Efficacy of Lianhua Qingwen Compared with Conventional Drugs in the Treatment of Common Pneumonia and COVID-19 Pneumonia: A Meta-AnalysisReview Article Published on 2020-09-172022-10-31 Journal: Evidence-based Complementary and Alternative Medicine : eCAM [Category] COVID-19, [키워드] 95% confidence interval Adverse reactions Chinese common Conventional cough COVID-19 criteria curative database drug English fatigue Fever flu-like symptom improvement indicated mean difference no significant difference Odds ratio Pain Pneumonia rale Result Severe case short duration Shortness of breath sputum statistically significant subgroup analysis subject therapy was used were used [DOI] 10.1155/2020/5157089 PMC 바로가기 [Article Type] Review Article
Efficacy and safety of chloroquine and hydroxychloroquine in the treatment of patients with COVID-19 combined with diabetes mellitus A protocol for systematic review and meta-analysis4900 Published on 2020-09-112022-10-30 Journal: Medicine [Category] COVID-19, SARS, [키워드] adverse outcomes Adverse reactions Analysis Anti-inflammatory Antiviral blood glucose can be used CBM Chinese Chloroquine Clinical improvement clinical trial CNKI Cochrane Library conducted country COVID-19 COVID-19 patient Data analysis database death diabete diabetes Diabetes Mellitus effective Effectiveness English Evidence fasting blood fasting insulin Glucose glycosylated HCQ hemoglobin Hospitalization Hydroxychloroquine ICU improvement include independent risk factor Infectious disease Lung imaging mechanical ventilation Meta-analysis metabolic disease mortality rate patients with COVID-19 peer-reviewed Primary outcome protocol Randomized controlled trials Registration review shown Symptom systematic review Treatment VIP virus nucleic acid Web of Science with COVID-19 [DOI] 10.1097/MD.0000000000022031 PMC 바로가기 [Article Type] 4900
A systematic review and meta-analysis of the efficacy and safety of western medicine routine treatment combined with Chinese herbal medicine in the treatment of COVID-194900 Published on 2020-08-072022-10-30 Journal: Medicine [Category] COVID-19, MERS, [키워드] 2019-nCoV adverse events Adverse reactions assist Blood CBM China Chinese Chinese herbal medicine CNKI Cochrane Library Complete Coronavirus disease 2019 COVID-19 data extraction effective Efficacy and safety eight evaluate Evidence Fatality rate Fever global public health Infectious disease lack Meta-analysis patient hospitalization peer-reviewed Pneumonia Prevent Primary outcome protocol Registration Research risk of bia secondary outcome Support symptomatic Symptoms systematic review therapy Traditional Chinese medicine Treatment VIP virus nucleic acid Western medicine [DOI] 10.1097/MD.0000000000021616 PMC 바로가기 [Article Type] 4900
A systematic review and meta-analysis of the efficacy and safety of arbidol in the treatment of coronavirus disease 20194900 Published on 2020-07-242022-10-30 Journal: Medicine [Category] COVID-19, SARS, [키워드] 2019 novel coronavirus adopted adverse events Adverse reactions Analysis antiviral drug Arbidol blood sample CBM Clinical efficacy CNKI Cochrane Library contagious coronavirus disease Coronavirus disease 2019 country COVID-19 database Descriptive analysis Effect Effectiveness Efficacy and safety Epidemic evaluate Evidence fixed heterogeneity Hospitalization include Meta-analysis Novel coronavirus novel coronavirus pneumonia nucleic acid Primary outcome protocol random-effects model Registration Research severe acute respiratory syndrome coronavirus 2 spread to subgroup analysis Symptoms systematic review temperature the epidemic Treatment umifenovir VIP [DOI] 10.1097/MD.0000000000021402 PMC 바로가기 [Article Type] 4900
Potential drugs for the treatment of the novel coronavirus pneumonia (COVID-19) in ChinaArticle Published on 2020-06-092022-10-04 Journal: Virus research [Category] SARS, 치료법, 치료제, [키워드] ACE2, angiotensin converting enzyme II ACE2angiotensin converting enzyme II activities acute respiratory distress syndrome Adverse reactions angiotensin converting enzyme II ARDS, acute respiratory distress syndrome ARDSacute respiratory distress syndrome articles Biological Biological products C-reactive protein cellular Characteristics Chemical drugs China China National Knowledge Infrastructure Chinese chronic obstructive pulmonary disease clinical trial clinical trials CNKI CNKI, China National Knowledge Infrastructure CNKIChina National Knowledge Infrastructure convalescent plasma COPD, Chronic obstructive pulmonary disease COPDchronic obstructive pulmonary disease Coronavirus disease 2019 COVID-19 COVID-19, Coronavirus disease 2019 COVID-19coronavirus disease 2019 CP, convalescent plasma CPconvalescent plasma CRP, C-reactive protein CRPC-reactive protein database dengue virus DENV, dengue virus DENVdengue virus drug drugs EC50, half effective concentration EC50half effective concentration effective drugs Effects Efficacy and safety Fangfeng Tongsheng Pill FFTS, Fangfeng Tongsheng Pill FFTSFangfeng Tongsheng Pill filtered GA, glycyrrhizic acid GAglycyrrhizic acid glycyrrhizic acid Government half effective concentration Health HIV, Human immunodeficiency virus HIVhuman immunodeficiency virus HSBD, Huashi Baidu Prescription HSBDHuashi Baidu Prescription Huashi Baidu Prescription Human immunodeficiency virus Huoxiang Zhengqi HXZQ, Huoxiang Zhengqi HXZQHuoxiang Zhengqi IFN-α, interferon-α IFN-αinterferon-α indications Infrastructure ingredient injection Interferon-α JHQG, Jinhua Qinggan Granule JHQGJinhua Qinggan Granule Jiedu Capsule Jinhua Qinggan Granule large sample LHQW, Lianhua Qingwen Capsule LHQWLianhua Qingwen Capsule Lianhua Qingwen capsule medication MERS-CoV, Middle East respiratory syndrome coronavirus MERS-CoVmiddle east respiratory syndrome coronavirus Mesenchymal stem cells Middle East respiratory syndrome Coronavirus MNV, murine norovirus MNVmurine norovirus MSCs, mesenchymal stem cells MSCsmesenchymal stem cells murine norovirus natural killer NCP, novel coronavirus pneumonia NCPnovel coronavirus pneumonia NK, natural killer NKnatural killer Novel coronavirus novel coronavirus pneumonia pharmacological Pneumonia Potential QFPD, Qingfei Paidu Decoction QFPDQingfei Paidu Decoction Qingfei Paidu decoction Randomized controlled trials RCTs, randomized controlled trials RCTsrandomized controlled trials researcher respiratory syncytial virus ribofuranosyl-5′-triphosphate RSV, respiratory syncytial virus RSVrespiratory syncytial virus RTP, ribofuranosyl-5′-triphosphate RTPribofuranosyl-5′-triphosphate SARS-CoV-2 SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2 SARS-CoV-2severe acute respiratory syndrome coronavirus 2 SARS-CoV, severe acute respiratory syndrome coronavirus SARS-CoVsevere acute respiratory syndrome coronavirus searched severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 Shufeng SFJD, Jiedu Capsule Shufeng SFJDJiedu Capsule stem cells TCM TCMs, traditional Chinese medicines TCMstraditional Chinese medicines therapeutic effect TJQW, Toujie Quwen Granule TJQWToujie Quwen Granule Toujie Quwen granule Traditional Chinese medicine traditional Chinese medicines treat Treatment Vaccines XFBD, Xuanfei Baidu Decoction XFBDXuanfei Baidu Decoction Xuanfei Baidu Decoction [DOI] 10.1016/j.virusres.2020.198057 PMC 바로가기 [Article Type] Article
Adverse reactions of dimethyl sulfoxide in humans: a systematic reviewarticle Published on 2019-08-062024-09-02 Journal: F1000Research [Category] 대상포진, [키워드] Adverse reactions Dimethyl sulfoxide DMSO toxicology [DOI] 10.12688/f1000research.16642.2 PMC 바로가기 [Article Type] article
Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran5가 백신 접종 후 이상사례: 이란에서 새로 도입된 백신의 경험Research Article Published on 2017-08-232024-07-27 Journal: BMC Immunology [Category] 백일해, 파상풍, [키워드] Adverse reactions immunization Iran Vaccine [DOI] 10.1186/s12865-017-0226-8 PMC 바로가기 [Article Type] Research Article